4 research outputs found

    Π‘Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ Π½ΠΎΠ²Ρ‹Ρ… Ρ€Π΅ΠΆΠΈΠΌΠΎΠ² профилактичСского лСчСния Ρ‚ΡƒΠ±Π΅Ρ€ΠΊΡƒΠ»Π΅Π·Π° ΠΈ ΠΏΡ€ΠΈΠ²Π΅Ρ€ΠΆΠ΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΊ ΠΈΡ… соблюдСнию ΠΏΠΎ Π΄Π°Π½Π½Ρ‹ΠΌ РСспублики ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½

    Get PDF
    The objective: to assess the safety and compliance with new regimens for preventive treatment of drug susceptible and drug resistant tuberculosis.Subjects and Methods. The study was carried out in Almaty, the Republic of Kazakhstan; 182 patients from the groups facing the high risk of developing active tuberculosis received preventive tuberculosis treatment with new regimens: 71 patients were treated with isoniazid and rifampicin for 3 months (3 HR), 55 - with isoniazid and rifapentine for 1 month (1 HR), 56 - with levofloxacin for 6 months (6 Lfx).Results. During treatment with regimens 3 HR, 1 HP, 6 Lfx, no adverse events of severity degree 3-4 developed , while adverse events of severity degree 1-2 were rare and relieved. The patient-oriented approach to the organization of preventive chemotherapy made it possible to achieve high treatment completion rates: in the group receiving 3 HR, it was 97.2% of cases, in the group receiving 1 HP - 96.4%, and in the group receiving 6 Lfx - 82.2%.ЦСль исслСдования: ΠΎΡ†Π΅Π½ΠΊΠ° бСзопасности ΠΈ привСрТСнности ΠΊ соблюдСнию Π½ΠΎΠ²Ρ‹Ρ… Ρ€Π΅ΠΆΠΈΠΌΠΎΠ² профилактичСского лСчСния лСкарствСнно Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ ΠΈ лСкарствСнно устойчивого Ρ‚ΡƒΠ±Π΅Ρ€ΠΊΡƒΠ»Π΅Π·Π°.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ИсслСдованиС Π²Ρ‹ΠΏΠΎΠ»Π½Π΅Π½ΠΎ Π² Π³. Алматы РСспублики ΠšΠ°Π·Π°Ρ…ΡΡ‚Π°Π½; Π½ΠΎΠ²Ρ‹Π΅ Ρ€Π΅ΠΆΠΈΠΌΡ‹ профилактичСского лСчСния Ρ‚ΡƒΠ±Π΅Ρ€ΠΊΡƒΠ»Π΅Π·Π° ΠΏΠΎΠ»ΡƒΡ‡ΠΈΠ»ΠΈ 182 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π° ΠΈΠ· Π³Ρ€ΡƒΠΏΠΏ высокого риска развития Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ Ρ‚ΡƒΠ±Π΅Ρ€ΠΊΡƒΠ»Π΅Π·Π°: 71 – ΠΈΠ·ΠΎΠ½ΠΈΠ°Π·ΠΈΠ΄ ΠΈ Ρ€ΠΈΡ„Π°ΠΌΠΏΠΈΡ†ΠΈΠ½ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 3 мСсяцСв (3 HR), 55 – ΠΈΠ·ΠΎΠ½ΠΈΠ°Π·ΠΈΠ΄ ΠΈ Ρ€ΠΈΡ„Π°ΠΏΠ΅Π½Ρ‚ΠΈΠ½ 1 мСсяц (1 НР), 56 – лСвофлоксацин 6 мСсяцСв (6 Lfx).Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΡ€ΠΈ ΠΏΡ€ΠΈΠ΅ΠΌΠ΅ Ρ€Π΅ΠΆΠΈΠΌΠΎΠ² 3 HR, 1 HP, 6 Lfx Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… явлСний 3-4 стСпСни тяТСсти Π½Π΅ наблюдалось, Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ явлСния 1-2 стСпСни токсичности Π²ΡΡ‚Ρ€Π΅Ρ‡Π°Π»ΠΈΡΡŒ Ρ€Π΅Π΄ΠΊΠΎ ΠΈ Π±Ρ‹Π»ΠΈ ΠΊΡƒΠΏΠΈΡ€ΠΎΠ²Π°Π½Ρ‹. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΎΡ€ΠΈΠ΅Π½Ρ‚ΠΈΡ€ΠΎΠ²Π°Π½Π½Ρ‹ΠΉ ΠΏΠΎΠ΄Ρ…ΠΎΠ΄ ΠΎΡ€Π³Π°Π½ΠΈΠ·Π°Ρ†ΠΈΠΈ ΠΏΡ€Π΅Π²Π΅Π½Ρ‚ΠΈΠ²Π½ΠΎΠΉ Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΠ» Π΄ΠΎΡΡ‚ΠΈΠ³Π½ΡƒΡ‚ΡŒ высоких ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ Π·Π°Π²Π΅Ρ€ΡˆΠ΅Π½ΠΈΡ лСчСния: Π² Π³Ρ€ΡƒΠΏΠΏΠ΅, ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠ΅ΠΉ 3 HR, Π² 97,2% случаСв, 1 HP – Π² 96,4% ΠΈ 6 Lfx – Π² 82,2%

    INCREASING THE VILLAGE OF THE MOBILE CONTROL STATION COMMUNICATION SYSTEM IN EMERGENCIES

    No full text
    The article describes the topical problems of ensuring the viability of communication systems of mobile control center in extreme and crisis situation and gives recommendation on their main solutions

    Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan

    No full text
    S E T T I N G : Kazakhstan is a country with a low HIV/ AIDS (human immunodeficiency virus/acquired immunedeficiency syndrome) burden, but a high prevalence of multidrug-resistant tuberculosis (MDR-TB). M E T H O D S We showed increasing HIV prevalence among TB patients in Kazakhstan. HIV was not an independent risk factor for MDR-TB, but risk factors were largely overlapping and we did identify subgroups at particular risk of HIV-MDR-TB co-infection, notably drug users. Enhanced efforts are necessary to provide care to these socially vulnerable populations
    corecore